Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Evolent Health Lowers FY2025 Sales Guidance from $2.060B-$2.110B to $1.850B-$1.880B vs $2.055B Est

Author: Benzinga Newsdesk | August 07, 2025 04:39pm
Evolent Health (NYSE:EVH) lowers FY2025 sales outlook from $2.060 billion-$2.110 billion to $1.850 billion-$1.880 billion vs $2.055 billion estimate.

Posted In: EVH

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist